Montreal, Canada – January 9 2006 - PainCeptor Pharma Corp. has accepted an invitation to speak at the “Emerging Company” stream of the 4th Annual BioPartnering North America (BPN) Conference to be held at the Westin Bayshore Resort in Vancouver, B.C., Canada, February 5-7, 2006. Dr. Louis Lamontagne, President & CEO of PainCeptor Pharma, will provide a company overview and update the status of its two most advanced programs for pain therapeutics, ASIC 1 and NGF/p75-trkA. Dr. Lamontagne’s podium presentation is scheduled for Tuesday, February 7, 12:00 noon.
